|
TWISTNB expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.499860E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.223170E-01 |
| Normal-vs-Stage2 |
2.651400E-01 |
| Normal-vs-Stage3 |
6.40989999999286E-05 |
| Normal-vs-Stage4 |
4.53020000001914E-06 |
| Stage1-vs-Stage2 |
8.061600E-01 |
| Stage1-vs-Stage3 |
1.319090E-03 |
| Stage1-vs-Stage4 |
2.181800E-04 |
| Stage2-vs-Stage3 |
1.833820E-01 |
| Stage2-vs-Stage4 |
1.119010E-01 |
| Stage3-vs-Stage4 |
6.305000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.564800E-03 |
| Normal-vs-AfricanAmerican |
1.964750E-04 |
| Normal-vs-Asian |
9.831900E-02 |
| Caucasian-vs-AfricanAmerican |
9.048500E-02 |
| Caucasian-vs-Asian |
6.208200E-01 |
| AfricanAmerican-vs-Asian |
8.444400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.723560E-03 |
| Normal-vs-Female |
1.252460E-02 |
| Male-vs-Female |
7.172800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.181700E-02 |
| Normal-vs-Age(41-60Yrs) |
5.980000E-03 |
| Normal-vs-Age(61-80Yrs) |
8.484800E-03 |
| Normal-vs-Age(81-100Yrs) |
2.916300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.672000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.577400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.252000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.517000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.870600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.059800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.024000E-01 |
| Normal-vs-Grade 2 |
3.388800E-01 |
| Normal-vs-Grade 3 |
1.72003999999726E-05 |
| Normal-vs-Grade 4 |
7.49959999657435E-08 |
| Grade 1-vs-Grade 2 |
6.093400E-01 |
| Grade 1-vs-Grade 3 |
1.516620E-01 |
| Grade 1-vs-Grade 4 |
5.040000E-02 |
| Grade 2-vs-Grade 3 |
7.61730000000682E-05 |
| Grade 2-vs-Grade 4 |
2.97110000047063E-07 |
| Grade 3-vs-Grade 4 |
3.253900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.102800E-01 |
| Normal-vs-ccB subtype |
2.284900E-03 |
| ccA subtype-vs-ccB subtype |
3.260400E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.664600E-03 |
| Normal-vs-N1 |
2.222400E-02 |
| N0-vs-N1 |
3.918600E-01 |
|
|
